Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone

PHASE3CompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Erectile DysfunctionHypogonadism
Interventions
DRUG

Testosterone gel

one sachet of 50 mg applied once a day, possibly titrated to two sachets if insufficient improvement of erectile function

DRUG

testosterone

testosterone gel, one sachet of 50 mg applied once a day, possibly titrated to 100 mg if insufficient effect

OTHER

placebo gel

one sachet of placebo gel once a day possibly titrated to 2 sachets if insufficient efficacy

Trial Locations (1)

59000

CETPARP/SelarlJBuvat, Lille

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

SELARL du Dr Jacques BUVAT

OTHER